<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01961479</url>
  </required_header>
  <id_info>
    <org_study_id>praemensis_2013</org_study_id>
    <nct_id>NCT01961479</nct_id>
  </id_info>
  <brief_title>Treatment of Premenstrual Syndrome - Internet-based Self-help</brief_title>
  <acronym>praemensis</acronym>
  <official_title>Development and Evaluation of an Internet-based Cognitive Behaviour Therapy for Women With Premenstrual Syndrome (PMS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Philipps University Marburg Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Linkoeping University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Philipps University Marburg Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether an internet-based CBT (iCBT) is effective
      in reducing the impairment caused by premenstrual symptoms.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Premenstrual syndrome (PMS) affects millions of women during their reproductive years. The
      disorder presents with emotional, cognitive, behavioural, and somatic symptoms during the
      final premenstrual phase and subsiding a few days after menses begins. About 75% of women of
      reproductive age experience a mild form of PMS (Campbell, Peterkin, O'Grady, &amp; Sanson-Fisher,
      1997). The more severe form of PMS, premenstrual dysphoric disorder (PMDD; American
      Psychiatric Association (APA), 1994) is considered to affect up to 8% of women of
      reproductive age. This severe form is associated with severe disruptions in normal
      functioning in work, family, or social relationships (Halbreich, Borenstein, Pearlstein, &amp;
      Kahn, 2003). The defining characteristics of both—PMS and PMDD— are the cyclic pattern of
      symptoms, which must be confirmed by prospective daily self ratings of symptoms (PMS-Diary)
      over two consecutive menstrual cycles (American College of Obstetricians and Gynecologists
      (ACOG), 2000). PMS and PMDD differ according to the number, severity, duration, and quality
      of symptoms.

      As a first-line intervention, the ACOG suggests pharmacotherapy, in particular selective
      serotonin reuptake inhibitors (SSRIs; ACOG, 2000). However, the side effects of SSRIs are
      intolerable to many women, leading to high rates of withdrawal from treatment (Busse et al.,
      2009; Dimmock, Wyatt, Jones, &amp; O'Brien, 2000). Thus, cognitive behavioural treatments (CBT)
      have been suggested as an additional treatment approach (Busse et al., 2009). First studies
      showed promising results for CBT interventions for PMS (Busse et al., 2009; Hunter et al.,
      2002). However, too few randomized controlled trials have carefully investigated the efficacy
      of CBT for PMS.

      The aim of the current study is thus to develop a CBT-oriented self-help treatment programme
      for women suffering from PMS or PMDD. The treatment programme consists of psychoeducation
      (e.g., information about PMS/PMDD and its aetiology), cognitive strategies (e.g., assessing
      and restructuring dysfunctional cognitions), and suggestions for lifestyle changes (e.g.,
      sports, balanced diet, relaxation). The programme is internet-delivered (iCBT) and
      participants work on different chapters for eight weeks in a row. In addition to written
      information, participants receive e-mail feedback from a psychologist on a weekly basis.
      Participants are required to have sufficient knowledge of German in order to be able to read
      the treatment materials. After a careful diagnostic assessment (including two months symptom
      diary), eligible patients are randomly assigned either to the treatment group or a waitlist
      control group. Participants assigned to the waitlist receive the treatment after the end of
      the waiting period (eight weeks). Follow-up assessments take place six months after the end
      of the treatment.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Actual">April 2018</completion_date>
  <primary_completion_date type="Actual">July 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Retrospective Screening (Ditzen et al., 2011)</measure>
    <time_frame>pre-treatment</time_frame>
    <description>assessment of premenstrual symptoms based on the Diagnostic and Statistical Manual of Mental Disorders Text Revision (DSM-IV-TR) (self-rating)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Prospective PMS-Diary (Kleinstäuber et al., unpublished)</measure>
    <time_frame>6 months; pre-treatment to post-treatment (4 months after admission)</time_frame>
    <description>prospective daily self ratings of premenstrual symptoms based on the DSM-IV-TR (self-rating)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Impairment by the premenstrual syndrome (self-developed questionnaire)</measure>
    <time_frame>10 months; pre-treatment (during luteal phase) to post-treatment (during luteal phase, 4 months after admission) to follow-up (during luteal phase, 10 months after admission)</time_frame>
    <description>assessment of cognitive, emotional and functional impairment by the premenstrual syndrome (self-rating)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Coping with the premenstrual symptoms (self-developed questionnaire)</measure>
    <time_frame>10 months; pre-treatment (during luteal phase) to post-treatment (during luteal phase, 4 months after admission) to follow-up (during luteal phase, 10 months after admission)</time_frame>
    <description>assessment of coping strategies (self-rating)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Coping Questionnaire (FESV; Geissner, 2003)</measure>
    <time_frame>10 months; pre-treatment (during luteal phase) to post-treatment (during luteal phase, 4 months after admission) to follow-up (during luteal phase, 10 months after admission)</time_frame>
    <description>assessment of PMS related coping strategies (self-rating)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Short Form Social Support Questionnaire (Fragebogen zur sozialen Unterstützung Kurzform (F-SozU K-22); Fydrich, Sommer, &amp; Brähler, 2007)</measure>
    <time_frame>10 months; pre-treatment (during luteal phase) to post-treatment (during luteal phase, 4 months after admission) to follow-up (during luteal phase, 10 months after admission)</time_frame>
    <description>assessment of the availability of social support (self-rating)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaire of the assessment of the partnership quality (FPQ; Siffert &amp; Bodenmann, 2010)</measure>
    <time_frame>10 months; pre-treatment (during luteal phase) to post-treatment (during luteal phase, 4 months after admission) to follow-up (during luteal phase, 10 months after admission)</time_frame>
    <description>assessment of partnership quality (self-rating)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effort-Reward Imbalance Questionnaire (ERI-Short-form; Siegrist, Wege, Pühlhofer, &amp; Wahrendorf, 2009)</measure>
    <time_frame>10 months; pre-treatment (during luteal phase) to post-treatment (during luteal phase, 4 months after admission) to follow-up (during luteal phase, 10 months after admission)</time_frame>
    <description>assessment of work strain (self-rating)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perceived stress scale (PSS, Cohen, 1994)</measure>
    <time_frame>10 months; pre-treatment (during luteal phase) to post-treatment (during luteal phase, 4 months after admission) to follow-up (during luteal phase, 10 months after admission)</time_frame>
    <description>assessment of stress perception (self-rating)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Big Five inventory (BFI-Short-form, John, Naumann, &amp; Soto, 2008)</measure>
    <time_frame>pre-treatment</time_frame>
    <description>assessment of personality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Disability Index (PDI; Dillmann, Nilges, Saile, &amp; Gerbershagen, 1994)</measure>
    <time_frame>10 months; pre-treatment (during luteal phase) to post-treatment (during luteal phase, 4 months after admission) to follow-up (during luteal phase, 10 months after admission)</time_frame>
    <description>assessment of the degree of daily impairment by chronic pain (self-rating)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">174</enrollment>
  <condition>Premenstrual Syndrome (PMS)</condition>
  <arm_group>
    <arm_group_label>Internet-based CBT for patients with PMS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The therapeutical intervention follows a treatment manual consisting of 14 modules. Patients work on up to two modules every week for eight weeks in a row. Modules comprise a) psychoeducation (e.g., information about PMS and its treatment); b) cognitive strategies (e.g., identifying and modifying dysfunctional cognitions, or coping with negative affects); and c) suggestions for lifestyle changes (e.g., sports, stress reduction, or balanced diet). Aim of the iCBT is to improve coping and thus to reduce the impairment due to premenstrual symptoms.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>waiting list</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>During the waiting period, patients receive no treatment. After a waiting time of 2 months, patients of the waitlist receive the same iCBT treatment as the experimental group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Internet-based CBT for patients with PMS</intervention_name>
    <description>Internet-based cognitive-behavioural self-help treatment</description>
    <arm_group_label>Internet-based CBT for patients with PMS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Waiting list</intervention_name>
    <description>During the waiting period, participants receive no treatment.</description>
    <arm_group_label>waiting list</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Fulfilling of particular diagnostic criteria: positive retrospective symptom screening
             &amp; confirmation of the diagnosis by a prospective PMS-Diary over 2 menstrual cycles

          -  Age 18-45 years

          -  Internet access

          -  Fluency in German

        Exclusion Criteria:

          -  Birth of a child or lactation going back to less than 3 months

          -  Pregnancy

          -  Symptoms exist less than three cycles

          -  Gynaecological diseases: Hysterectomy, Gynaecological cancer, Polycystic ovary
             syndrome, Endometriosis, Infertility

          -  Current diagnosis of psychosis or bipolar disorder

          -  Current diagnosis of eating-disorder

          -  Current diagnosis of average or severe depression

          -  Current diagnosis of somatisation disorder

          -  Acute suicidal tendency

          -  participation in psychotherapy due to premenstrual syndrome, currently or in the past

          -  Begin to take antidepressants or a change of the active pharmaceutical ingredient
             during the last three months

          -  Begin to take a combined oral contraceptive pill or a change of the preparation during
             the last three months

          -  Begin to take hormones or a change of the hormone supplement during the last three
             months

          -  The taking of Benzodiazepines/Antipsychotics
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cornelia Weise, Ph.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Philipps University Marburg Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Maria Kleinstäuber, Ph.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Philipps University Marburg Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Carolyn Janda, Ph.D.Student</last_name>
    <role>Study Chair</role>
    <affiliation>Philipps University Marburg Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Johanna N. Kues, Ph.D.Student</last_name>
    <role>Study Chair</role>
    <affiliation>Philipps University Marburg Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gudrun Kaiser, Ph.D Student</last_name>
    <role>Study Chair</role>
    <affiliation>Philipps University Marburg Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Philipps University Marburg, Dept. of Psychology, Division of Clinical Psychology and Psychotherapy</name>
      <address>
        <city>Marburg</city>
        <state>Hessen</state>
        <zip>35037</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://www.uni-marburg.de/fb04/ag-klin/forschung/pmsd/index_html</url>
    <description>Click here for more information about this study: Treatment of the Premenstrual Syndrome - Internet-based self-help</description>
  </link>
  <reference>
    <citation>Busse JW, Montori VM, Krasnik C, Patelis-Siotis I, Guyatt GH. Psychological intervention for premenstrual syndrome: a meta-analysis of randomized controlled trials. Psychother Psychosom. 2009;78(1):6-15. doi: 10.1159/000162296. Epub 2008 Oct 14.</citation>
    <PMID>18852497</PMID>
  </reference>
  <reference>
    <citation>Campbell EM, Peterkin D, O'Grady K, Sanson-Fisher R. Premenstrual symptoms in general practice patients. Prevalence and treatment. J Reprod Med. 1997 Oct;42(10):637-46.</citation>
    <PMID>9350019</PMID>
  </reference>
  <reference>
    <citation>Dimmock PW, Wyatt KM, Jones PW, O'Brien PM. Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review. Lancet. 2000 Sep 30;356(9236):1131-6.</citation>
    <PMID>11030291</PMID>
  </reference>
  <reference>
    <citation>Halbreich U, Borenstein J, Pearlstein T, Kahn LS. The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). Psychoneuroendocrinology. 2003 Aug;28 Suppl 3:1-23. Review.</citation>
    <PMID>12892987</PMID>
  </reference>
  <reference>
    <citation>Hunter MS, Ussher JM, Cariss M, Browne S, Jelley R, Katz M. Medical (fluoxetine) and psychological (cognitive-behavioural therapy) treatment for premenstrual dysphoric disorder: a study of treatment processes. J Psychosom Res. 2002 Sep;53(3):811-7.</citation>
    <PMID>12217456</PMID>
  </reference>
  <reference>
    <citation>Siegrist J, Wege N, Pühlhofer F, Wahrendorf M. A short generic measure of work stress in the era of globalization: effort-reward imbalance. Int Arch Occup Environ Health. 2009 Aug;82(8):1005-13. doi: 10.1007/s00420-008-0384-3. Epub 2008 Nov 19.</citation>
    <PMID>19018554</PMID>
  </reference>
  <reference>
    <citation>Dillmann U, Nilges P, Saile H, Gerbershagen HU. [Assessing disability in chronic pain patients.]. Schmerz. 1994 Jun;8(2):100-10. German.</citation>
    <PMID>18415443</PMID>
  </reference>
  <reference>
    <citation>Kleinstäuber M, Witthöft M, Hiller W. Cognitive-behavioral and pharmacological interventions for premenstrual syndrome or premenstrual dysphoric disorder: a meta-analysis. J Clin Psychol Med Settings. 2012 Sep;19(3):308-19. doi: 10.1007/s10880-012-9299-y. Review.</citation>
    <PMID>22426857</PMID>
  </reference>
  <reference>
    <citation>American College of Obstetricians and Gynecologists (ACOG). Premenstrual syndrome. Washington, DC: National Guideline Clearinghouse, 2000.</citation>
  </reference>
  <reference>
    <citation>American Psychiatric Association (APA). Diagnostic and statistical manual for mental disorders (DSM-IV). Washington, DC: American Psychiatric Press, 1994.</citation>
  </reference>
  <reference>
    <citation>Cohen S. Perceived stress scale, 1994. Retrieved August 09, 2012, from http://updates.wcupa.edu/_academics/healthsciences/stressreductioncenter/documents/perceived_stress_scale.pdf</citation>
  </reference>
  <reference>
    <citation>Ditzen B, Nussbeck F, Drobnjak S, Spörri C, Wüest D, Ehlert U. Validierung eines deutschsprachigen DSM-IV-TR basierten Fragebogens zum prämenstruellen Syndrom. Zeitschrift für Klinische Psychologie und Psychotherapie 40(3): 149-159, 2011.</citation>
  </reference>
  <reference>
    <citation>Fydrich T, Sommer G, &amp; Brähler E. Fragebogen zur sozialen Unterstützung (F-SozU ). Göttingen: Hogrefe, 2007.</citation>
  </reference>
  <reference>
    <citation>Geissner E. Pain Coping Questionnaire FESV. Göttingen, Germany: Hogrefe, 2003.</citation>
  </reference>
  <reference>
    <citation>Siffert A, Bodenmann G. Entwicklung eines neuen multidimensionalen Fragebogens zur Erfassung der Partnerschaftsqualität (FPQ). Zeitschrift für Familienforschung, 2010.</citation>
  </reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 9, 2013</study_first_submitted>
  <study_first_submitted_qc>October 9, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 11, 2013</study_first_posted>
  <last_update_submitted>April 10, 2018</last_update_submitted>
  <last_update_submitted_qc>April 10, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Philipps University Marburg Medical Center</investigator_affiliation>
    <investigator_full_name>Cornelia Weise</investigator_full_name>
    <investigator_title>Dr. rer. nat.</investigator_title>
  </responsible_party>
  <keyword>Premenstrual syndrome (PMS)</keyword>
  <keyword>Premenstrual Dysphoric Disorder (PMDD)</keyword>
  <keyword>Internet-based Therapy</keyword>
  <keyword>Cognitive Behavioural Therapy (CBT)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Premenstrual Syndrome</mesh_term>
  </condition_browse>
  <study_docs>
    <study_doc>
      <doc_type>Study Protocol</doc_type>
      <doc_url>http://trialsjournal.biomedcentral.com/articles/10.1186/1745-6215-15-472</doc_url>
      <doc_comment>Kues, J. N., Janda, C., Kleinstaeuber, M., &amp; Weise, C. (2014). Internet-based cognitive behavioural self-help for premenstrual syndrome: study protocol for a randomised controlled trial. Trials, 15(1), 472. doi:10.1186/1745-6215-15-472</doc_comment>
    </study_doc>
    <study_doc>
      <doc_type>Study Protocol</doc_type>
      <doc_url>http://www.karger.de/ProdukteDB/miscArchiv/000/439/336/000439336_sm_Eversion.pdf</doc_url>
      <doc_comment>Janda, C., Kues, J. N., Kleinstaeuber, M., &amp; Weise, C. (2015). A Therapeutic Approach to Premenstrual Syndrome (PMS): Modularized Treatment Program. Verhaltenstherapie, 25. doi:10.1159/000439336</doc_comment>
    </study_doc>
    <study_doc>
      <doc_type>Questionnaire Validation</doc_type>
      <doc_url>http://www.tandfonline.com/doi/abs/10.1080/03630242.2015.1118734?journalCode=wwah20</doc_url>
      <doc_comment>Kues, J. N., Janda, C., Kleinstäuber, M., &amp; Weise, C. (2015). How to Measure the Impact of Premenstrual Symptoms? Development and Validation of the German PMS-Impact Questionnaire. Women &amp; Health, null-null. doi:10.1080/03630242.2015.1118734</doc_comment>
    </study_doc>
  </study_docs>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

